Sector valuations Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.76 USD | -0.38% |
|
-1.99% | +0.51% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -9.74x | - | -0.04x | - | - | - | - | 134.45Cr | ||
| 34.04x | 4.53x | 1.31x | 6.07x | 18.06x | 25.4x | 0.94% | 4.95TCr | ||
| -21.52x | 22.46x | -0.35x | 306.46x | -21.8x | -21.04x | -.--% | 4.41TCr | ||
| 47.48x | 7.68x | 0.24x | 5.43x | 29.82x | 34.45x | -.--% | 4.08TCr | ||
| 31.16x | 5.69x | -32.65x | 3.08x | 13.3x | 20.09x | -.--% | 4.01TCr | ||
| 30.58x | 2.49x | 0.64x | 8.82x | 22.17x | 26.41x | 0.38% | 3.42TCr | ||
| 34.26x | 24.58x | 2.27x | 5.61x | 25.51x | 26.69x | -.--% | 1.69TCr | ||
| 23.3x | 2.61x | 0.67x | 2.04x | 8.84x | 13.56x | 1.15% | 1.4TCr | ||
| 74.11x | 4.39x | -0.32x | 3.92x | 15.21x | 18.68x | -.--% | 1.35TCr | ||
| 28.13x | 1.34x | 0.27x | 1.88x | 11.57x | 13.18x | -.--% | 1.28TCr | ||
| 43.83x | 4.83x | 3.08x | 5.03x | 21.19x | 33.47x | 0.51% | 1.18TCr | ||
| 60.61x | 5.18x | 0.38x | 9.23x | 26.26x | 28.69x | 0.44% | 1.12TCr | ||
| -31.33x | 9.22x | 1.18x | 113.11x | -32.2x | -56.03x | -.--% | 1.09TCr | ||
| -27.05x | 9.12x | -42.78x | 10186.71x | -21.84x | -21.51x | -.--% | 1.03TCr | ||
| -28.02x | 9.24x | -2.02x | - | -26.59x | -24.4x | -.--% | 1.01TCr | ||
| -38.6x | 20.2x | -32.98x | 6.55x | 160.42x | -2134.65x | -.--% | 1TCr | ||
| 32.39x | - | -0.1x | 16.92x | 32.12x | 30.51x | -.--% | 959.56Cr | ||
| -15.93x | 659.18x | -0.32x | 10.16x | -16.43x | -15.87x | -.--% | 920.99Cr | ||
| 21.01x | 2.42x | 2.77x | 4.51x | 12.02x | 15.33x | 0.59% | 882Cr | ||
| Average | 15.20x | 46.77x | -5.20x | 629.15x | 15.42x | -110.39x | 0.22% | 1.89TCr | |
| Weighted average by Cap. | 20.80x | 26.03x | -5.30x | 350.26x | 13.75x | -47.56x | 0.26% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















